The leading source for product info and unbiased product reviews View this email online SHARE THIS: Email   |   Facebook   |   Twitter
Biocompare - Application Focus newsletter
Protein Expression
Application Notes »         Most Popular Articles »          Featured Product »
 
You have been selected to receive this newsletter based on your interest in learning more about protein expression. It contains some of our most popular protein expression related content. Read on and let us help you advance your research.
 
Sponsored by
learn more »
Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including ...
Most Popular Articles
more
more
Application Notes
more
Bispecific Antibodies Rising Stars in Antibody Therapeutics
In January 2022, Faricimab (Vabysmo, Roche) has been approved by FDA to treat wet age-related macular degeneration (AMD) and diabetic macular edema (DME). ...  Download »
more
The Production and Application of Antibody Fragments
Antibodies are modular defense systems that identify and neutralize foreign objects like bacteria and viruses. Each of them could recognize a specific antigen ...  Download »
more
Recombinant Protein Expression Challenges and Solutions
Proteins are bio-macromolecules with complex higher-order structures and a variety of functionalities. As the end products of the “central dogma” in biology, ...  Download »
Featured Product
learn more
Recombinant Protein Expression Services
With 1,000+ new proteins in R&D each year, Sino Biological has extensive experience in producing recombinant proteins such as transmembrane proteins, enzymes, kinases, viral antigens, etc. We provide complete services from gene cloning and synthesis to protein characterization. ...  More »
 
Biocompare
You received this email because you are subscribed
to our database. Need to change your settings?
Email Settings or Unsubscribe here